SK176998A3 - Nasal administration of desmopressin - Google Patents

Nasal administration of desmopressin Download PDF

Info

Publication number
SK176998A3
SK176998A3 SK1769-98A SK176998A SK176998A3 SK 176998 A3 SK176998 A3 SK 176998A3 SK 176998 A SK176998 A SK 176998A SK 176998 A3 SK176998 A3 SK 176998A3
Authority
SK
Slovakia
Prior art keywords
desmopressin
volume
solution
composition
compound
Prior art date
Application number
SK1769-98A
Other languages
English (en)
Slovak (sk)
Inventor
Bengt Bengtsson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of SK176998A3 publication Critical patent/SK176998A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1769-98A 1996-06-20 1997-06-10 Nasal administration of desmopressin SK176998A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/667,047 US5763398A (en) 1996-06-20 1996-06-20 Nasal administration of desmopressin
PCT/SE1997/001010 WO1997048379A1 (en) 1996-06-20 1997-06-10 Nasal administration of desmopressin

Publications (1)

Publication Number Publication Date
SK176998A3 true SK176998A3 (en) 1999-05-07

Family

ID=24676595

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1769-98A SK176998A3 (en) 1996-06-20 1997-06-10 Nasal administration of desmopressin

Country Status (24)

Country Link
US (1) US5763398A (xx)
EP (1) EP0921786A1 (xx)
JP (1) JP2000502358A (xx)
KR (1) KR20000016781A (xx)
CN (1) CN1233952A (xx)
AU (1) AU707527B2 (xx)
BR (1) BR9700797A (xx)
CA (1) CA2258552A1 (xx)
CZ (1) CZ420198A3 (xx)
EE (1) EE9800453A (xx)
HU (1) HUP9903541A3 (xx)
IL (1) IL127572A (xx)
LT (1) LT4621B (xx)
LV (1) LV12230B (xx)
NO (1) NO985936L (xx)
NZ (1) NZ333124A (xx)
PL (1) PL330902A1 (xx)
RO (1) RO120170B1 (xx)
RU (1) RU2173559C2 (xx)
SI (1) SI9720040A (xx)
SK (1) SK176998A3 (xx)
TR (1) TR199802596T2 (xx)
UA (1) UA49888C2 (xx)
WO (1) WO1997048379A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ATE324869T1 (de) * 2003-11-13 2006-06-15 Ferring Bv Blisterverpackung und feste dosierungsform enthaltend desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
ES2319054B1 (es) * 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
LT2712622T (lt) * 2008-05-21 2016-09-26 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
EP2334234A4 (en) 2008-09-19 2013-03-20 Tandem Diabetes Care Inc DEVICE FOR MEASURING THE CONCENTRATION OF A SOLVED SUBSTANCE AND CORRESPONDING METHOD
EP2381923B2 (en) * 2008-12-22 2023-06-07 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
DK3679941T3 (da) 2009-06-18 2022-11-14 Serenity Pharmaceuticals Llc Sikker indgivelse af desmopressin
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
FR2954774B1 (fr) * 2009-10-30 2012-01-06 Michelin Soc Tech Methode de preparation d'un melange maitre de caoutchouc naturel et de silice
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
RU2605311C1 (ru) * 2015-07-14 2016-12-20 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Способ лечения болевого синдрома у больных с дегенеративно-дистрофическими заболеваниями позвоночника

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
JPH09502425A (ja) * 1993-06-29 1997-03-11 フエリング ビー ヴイ デスモプレッシン鼻腔投与用組成
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin

Also Published As

Publication number Publication date
CA2258552A1 (en) 1997-12-24
AU3280297A (en) 1998-01-07
SI9720040A (sl) 1999-08-31
RU2173559C2 (ru) 2001-09-20
KR20000016781A (ko) 2000-03-25
CN1233952A (zh) 1999-11-03
EP0921786A1 (en) 1999-06-16
IL127572A0 (en) 1999-10-28
NO985936D0 (no) 1998-12-17
NZ333124A (en) 1999-05-28
NO985936L (no) 1999-02-16
HUP9903541A2 (hu) 2000-04-28
WO1997048379A1 (en) 1997-12-24
HUP9903541A3 (en) 2000-10-30
EE9800453A (et) 1999-08-16
RO120170B1 (ro) 2005-10-28
UA49888C2 (uk) 2002-10-15
JP2000502358A (ja) 2000-02-29
LV12230A (lv) 1999-03-20
LV12230B (en) 1999-06-20
LT98188A (en) 1999-11-25
CZ420198A3 (cs) 1999-04-14
US5763398A (en) 1998-06-09
TR199802596T2 (xx) 1999-03-22
AU707527B2 (en) 1999-07-15
LT4621B (lt) 2000-02-25
IL127572A (en) 2003-04-10
PL330902A1 (en) 1999-06-07
BR9700797A (pt) 1998-10-06

Similar Documents

Publication Publication Date Title
SK176998A3 (en) Nasal administration of desmopressin
EP0710122B1 (en) Stabilized pharmaceutical peptide compositions
EP0708657B1 (en) Compositions for nasal administration of desmopressin
USRE43580E1 (en) Nasal calcitonin formulations
AU2017281941A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
US20200390691A1 (en) Compositions, devices, and methods for the treatment of overdose and reward-based disorders
CN102378605A (zh) 用于经鼻递送的肽药物
MXPA97000440A (en) Pharmaceutical composition nasod administrable monodosis and method of application of such composic
IT9021264A1 (it) Composizioni farmaceutiche per la somministrazione intranasale di calcitonina
GB2417202A (en) Pharmaceutical preparation comprising calcitonin